Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

Europe - FRA:ABO - DE000A1EWXA4 - Common Stock

1.43 EUR
0 (0%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

4

ABO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 23 industry peers in the Independent Power and Renewable Electricity Producers industry. While ABO is still in line with the averages on profitability rating, there are concerns on its financial health. ABO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ABO has reported negative net income.
In the past year ABO had a positive cash flow from operations.
Of the past 5 years ABO 4 years were profitable.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

The Return On Assets of ABO (-0.17%) is comparable to the rest of the industry.
ABO has a Return On Equity of -0.44%. This is comparable to the rest of the industry: ABO outperforms 43.48% of its industry peers.
With a Return On Invested Capital value of 0.99%, ABO is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ABO is below the industry average of 5.45%.
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROIC 0.99%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

ABO's Operating Margin of 18.27% is fine compared to the rest of the industry. ABO outperforms 65.22% of its industry peers.
ABO's Operating Margin has declined in the last couple of years.
ABO has a Gross Margin of 96.58%. This is amongst the best in the industry. ABO outperforms 95.65% of its industry peers.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.27%
PM (TTM) N/A
GM 96.58%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ABO has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ABO has more shares outstanding
Compared to 1 year ago, ABO has a worse debt to assets ratio.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that ABO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.56, ABO is doing worse than 69.57% of the companies in the same industry.
ABO has a debt to FCF ratio of 22.35. This is a negative value and a sign of low solvency as ABO would need 22.35 years to pay back of all of its debts.
ABO has a better Debt to FCF ratio (22.35) than 73.91% of its industry peers.
ABO has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
ABO has a Debt to Equity ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Altman-Z 0.56
ROIC/WACC0.28
WACC3.57%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.61 indicates that ABO should not have too much problems paying its short term obligations.
ABO has a Current ratio of 1.61. This is comparable to the rest of the industry: ABO outperforms 56.52% of its industry peers.
A Quick Ratio of 1.61 indicates that ABO should not have too much problems paying its short term obligations.
The Quick ratio of ABO (1.61) is better than 60.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.42%.
Looking at the last year, ABO shows a very negative growth in Revenue. The Revenue has decreased by -19.53% in the last year.
Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 1.75% on average per year.
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%

3.2 Future

ABO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.40% yearly.
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 8.57% on average per year.
EPS Next Y191.47%
EPS Next 2Y82.13%
EPS Next 3Y53.4%
EPS Next 5YN/A
Revenue Next Year15.44%
Revenue Next 2Y13.51%
Revenue Next 3Y8.57%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABO. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 39.33 indicates a quite expensive valuation of ABO.
ABO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ABO is more expensive than 69.57% of the companies in the same industry.
ABO is valuated expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 39.33
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

ABO's Enterprise Value to EBITDA is on the same level as the industry average.
ABO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABO is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.19
EV/EBITDA 14.27
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ABO's earnings are expected to grow with 53.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.13%
EPS Next 3Y53.4%

5

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 4.20%, which is a nice return.
Compared to an average industry Dividend Yield of 3.44, ABO pays a bit more dividend than its industry peers.
ABO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 4.2%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y82.13%
EPS Next 3Y53.4%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

CLEARVISE AG

FRA:ABO (10/31/2025, 7:00:00 PM)

1.43

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-14 2025-11-14
Inst Owners5.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap107.76M
Revenue(TTM)35.41M
Net Income(TTM)-707700
Analysts87.5
Price Target2.82 (97.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.2%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)205.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 39.33
P/S 3.04
P/FCF 10.19
P/OCF 10.19
P/B 0.67
P/tB 0.67
EV/EBITDA 14.27
EPS(TTM)-0.01
EYN/A
EPS(NY)0.04
Fwd EY2.54%
FCF(TTM)0.14
FCFY9.81%
OCF(TTM)0.14
OCFY9.81%
SpS0.47
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROCE 1.64%
ROIC 0.99%
ROICexc 1.05%
ROICexgc 1.05%
OM 18.27%
PM (TTM) N/A
GM 96.58%
FCFM 29.86%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ROICexc(3y)3.53%
ROICexc(5y)2.94%
ROICexgc(3y)3.56%
ROICexgc(5y)2.99%
ROCE(3y)4.91%
ROCE(5y)4.17%
ROICexgc growth 3Y9.45%
ROICexgc growth 5Y-12.72%
ROICexc growth 3Y10.45%
ROICexc growth 5Y-12.08%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Debt/EBITDA 9.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 47.02%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 0.56
F-Score4
WACC3.57%
ROIC/WACC0.28
Cap/Depr(3y)124.13%
Cap/Depr(5y)91.46%
Cap/Sales(3y)46.11%
Cap/Sales(5y)37.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y191.47%
EPS Next 2Y82.13%
EPS Next 3Y53.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%
Revenue Next Year15.44%
Revenue Next 2Y13.51%
Revenue Next 3Y8.57%
Revenue Next 5YN/A
EBIT growth 1Y-60.34%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year457.55%
EBIT Next 3Y84.39%
EBIT Next 5YN/A
FCF growth 1Y-70.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.97%
OCF growth 3Y-7.16%
OCF growth 5Y-8.38%

CLEARVISE AG / ABO.DE FAQ

Can you provide the ChartMill fundamental rating for CLEARVISE AG?

ChartMill assigns a fundamental rating of 4 / 10 to ABO.DE.


What is the valuation status of CLEARVISE AG (ABO.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CLEARVISE AG (ABO.DE). This can be considered as Fairly Valued.


What is the profitability of ABO stock?

CLEARVISE AG (ABO.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for ABO stock?

The financial health rating of CLEARVISE AG (ABO.DE) is 3 / 10.